We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+8.97%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$47.8B
AUM Growth
-$2.34B
(-4.7%)
Cap. Flow
-$5.56B
Cap. Flow
% of AUM
-11.64%
Top 10 Holdings %
Top 10 Hldgs %
32.03%
Holding
2,131
New
54
Increased
334
Reduced
1,616
Closed
126
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thomson Reuters
TRI
|
+$89.7M |
| 2 |
Fortinet
FTNT
|
+$69.3M |
| 3 |
Flowers Foods
FLO
|
+$37.9M |
| 4 |
Brown & Brown
BRO
|
+$28.6M |
| 5 |
Consolidated Edison
ED
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$626M |
| 2 |
Microsoft
MSFT
|
+$454M |
| 3 |
Apple
AAPL
|
+$414M |
| 4 |
Broadcom
AVGO
|
+$317M |
| 5 |
Amazon
AMZN
|
+$270M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Consumer Discretionary | 10.23% |
| 3 | Industrials | 9.49% |
| 4 | Communication Services | 9.26% |
| 5 | Financials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Agilon Health
AGL
$1.64B
| $54.4K | ﹤0.01% |
2,111
-421
| -17% | -$15.9K |
|
1927
AbCellera Biologics
ABCL
$1.62B
| $53.5K | ﹤0.01% |
10,646
-500
| -4% | -$2.2K |
|
1928
Claros Mortgage Trust
CMTG
$306M
| $52.4K | ﹤0.01% |
15,785
-3,145
| -17% | -$10.6K |
|
|
ALMS
1929
Alumis Inc
ALMS
$3.57B
| $51.9K | ﹤0.01% |
13,009
-452
| -3% | -$1.86K |
|
1930
Krispy Kreme
DNUT
$543M
| $51K | ﹤0.01% |
13,191
-2,628
| -17% | -$9.06K |
|
1931
Richtech Robotics
RR
$347M
| $50.7K | ﹤0.01% |
11,826
-2,356
| -17% | -$6.2K |
|
1932
Cerus
CERS
$587M
| $50.2K | ﹤0.01% |
31,582
-6,292
| -17% | -$8.5K |
|
|
BRY
1933
DELISTED
Berry Corp
BRY
| $49.8K | ﹤0.01% |
13,175
-2,626
| -17% | -$8.51K |
|
1934
ADC Therapeutics
ADCT
$146M
| $49.6K | ﹤0.01% |
12,388
-2,467
| -17% | -$7.78K |
|
1935
National CineMedia
NCMI
$354M
| $49.4K | ﹤0.01% |
10,962
-2,185
| -17% | -$10.2K |
|
1936
Organogenesis Holdings
ORGO
$308M
| $49.3K | ﹤0.01% |
11,679
-2,326
| -17% | -$10.8K |
|
1937
ZipRecruiter
ZIP
$318M
| $49.1K | ﹤0.01% |
11,639
-1,794
| -13% | -$8.39K |
|
1938
Blue Ridge Bankshares
BRBS
$311M
| $48.8K | ﹤0.01% |
11,535
-1,639
| -12% | -$6.35K |
|
1939
8x8 Inc
EGHT
$247M
| $48.5K | ﹤0.01% |
22,875
-3,867
| -14% | -$7.78K |
|
1940
Humacyte
HUMA
$168M
| $47.1K | ﹤0.01% |
27,072
-4,421
| -14% | -$8.66K |
|
1941
Atea Pharmaceuticals
AVIR
$379M
| $46.2K | ﹤0.01% |
15,934
-2,978
| -16% | -$10.2K |
|
1942
SelectQuote
SLQT
$114M
| $46.1K | ﹤0.01% |
23,502
-4,681
| -17% | -$9.9K |
|
1943
Alector
ALEC
$164M
| $45.7K | ﹤0.01% |
15,431
-4,647
| -23% | -$10.2K |
|
1944
Unisys
UIS
$227M
| $44.5K | ﹤0.01% |
11,410
-2,273
| -17% | -$9.22K |
|
1945
loanDepot
LDI
$548M
| $43.5K | ﹤0.01% |
14,171
-2,572
| -15% | -$5.94K |
|
1946
Ironwood Pharmaceuticals
IRWD
$611M
| $43.4K | ﹤0.01% |
33,145
-5,707
| -15% | -$5.91K |
|
|
BZAI
1947
Blaize Holdings
BZAI
$129M
| $43.2K | ﹤0.01% |
+12,522
| New | +$44.5K |
|
1948
Codexis
CDXS
$135M
| $42K | ﹤0.01% |
17,215
-2,668
| -13% | -$7.28K |
|
1949
Allogene Therapeutics
ALLO
$601M
| $41.9K | ﹤0.01% |
33,830
-5,430
| -14% | -$6.47K |
|
1950
Hyliion Holdings
HYLN
$663M
| $41.8K | ﹤0.01% |
21,198
-5,368
| -20% | -$8.94K |
|
Similar funds
ProShare Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, ProShare Advisors held 2,131 positions worth $47.8B, down 4.7% from $50.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
ProShare Advisors withdrew a net $5.56B in Q3 2025, closing 126 positions and reducing 1,616 holdings. Its most notable exit was Ansys, an estimated $48.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, ProShare Advisors opened a new position in Thomson Reuters worth $75.8M.
- ProShare Advisors's largest Q3 2025 buy was Thomson Reuters: 480,707 shares worth $75.8M.
- ProShare Advisors added most to Fortinet in Q3 2025, an estimated $69.3M increase.
- ProShare Advisors's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $626M.
- ProShare Advisors fully exited Ansys in Q3 2025, selling an estimated $48.7M.
- ProShare Advisors's ten largest holdings make up 32% of its $47.8B portfolio in Q3 2025.
- ProShare Advisors opened 54 new positions and closed 126 in Q3 2025.
- ProShare Advisors's portfolio value fell 4.7% quarter-over-quarter to $47.8B.
Based on ProShare Advisors's 13F filing for Q3 2025, filed 6 Nov 2025.